TRIUMPH-1, the pivotal obesity trial, reported on May 21, 2026 , and TRIUMPH-2 (obesity in type 2 diabetes) and TRIUMPH-3 (obesity with established cardiovascular disease) both reported on July 23, 2026 so the core evidence package for this filing is in hand
[5]Aging changes in hormone production: MedlinePlus Medical Encyclopedia. (accessed Nov
05 Short, comfortable observation period to ensure safety, hydration, and optimal response
This includes pancreatitis and kidney damage
Lipotropic injections may be considered for some individuals when administered by a licensed healthcare provider as part of a medically supervised weight management program
Off-label prescribing involves using an approved drug for a purpose outside its official listing, and is a normal, legal, and common part of medicine when its backed by good evidence